Products
Powder Ovarian Cell Model
The Powder cell model originates from serous carcinoma of the ovary.
Product Family: Powder Ovarian Cell Model
Disease Area: Cancer
Tissue Type: Ovary
Clinical Diagnosis: Serous carcinoma of the ovary
| Disease Area: | Cancer |
| Tissue Type: | Ovary |
| Clinical Diagnosis: | Serous carcinoma of the ovary |
| Age: | 65-69 |
| Sex: | Female |
| Ethnicity: | Caucasian |
| TNM Stage: | T3cN1M1 |
| Grade: | IV |
| Co-indications: | N/A |
| Medications: | Adderall, Fosamax, Claritin, Calcium Carbonate and Vitamin D, Effexor, Hydrocodone and Acetaminophen, Triamterene |
| Country of Collection: | United States |
| Year of Origin: | 2012 |
Gene Mutations
| Gene | Alteration | Frequency (%) | Exon | Result |
| SMO | L23dup | 28 | 1 | Mutated, Presumed Benign |
Powder Growth Characteristics
The historical growth curve of Powder demonstrates consistent growth and highlights the lack of cell crisis.
STR Profile
AMEL: X
CSF1PO: 11, 12
D13S317: 12
D16S539: 9, 11
D18S51: 14, 19
D21S11: 28, 31.2
D3S1358: 14, 16
D5S818: 12
D7S820: 9
D8S1179: 11, 13
FGA: 22, 23
Penta D: 12, 13
Penta E: 13, 17
TH01: 7, 8
TPOX: 8, 9
vWA: 17, 19
Immunohistochemistry
Tumor sample diagnosis was confirmed by histology and immunohistochemical detection of tumor markers.
Lineage Markers
Immunofluorescence detection of lineage markers confirm epithelial phenotype using CK7 with DAPI overlay.
Tumorsphere Formation
Spontaneous formation of tumorspheres under low-attachment conditions.
N/A
Storage and Stability: Store frozen in liquid nitrogen.
Care and Use Instructions: See protocol for further details
Quality Control: All lots are tested for microbial and viral contamination, cell line cross-contamination, mycoplasma, and consistent growth capabilities. See Certificate of Analysis for further details.
Connect With Us
Learn more about how Cellaria can help transform your research efficacy.